These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3689436)

  • 21. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
    Nicholson CD; Jackman SA; Wilke R
    Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX) inhibition of [3H]N-ethylcarboxamidoadenosine (NECA) binding allows the visualization of putative non-A1 adenosine receptors.
    Lee KS; Reddington M
    Brain Res; 1986 Mar; 368(2):394-8. PubMed ID: 3008930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ischaemia on cardiac adenosine binding sites.
    Ronca-Testoni S; Zucchi R; Limbruno U; Galbani P; Ronca G; Mariani M
    Adv Exp Med Biol; 1991; 309A():447-50. PubMed ID: 1789264
    [No Abstract]   [Full Text] [Related]  

  • 24. Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus.
    Mayfield RD; Suzuki F; Zahniser NR
    J Neurochem; 1993 Jun; 60(6):2334-7. PubMed ID: 8492136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
    Daly JW; Padgett W; Shamim MT; Butts-Lamb P; Waters J
    J Med Chem; 1985 Apr; 28(4):487-92. PubMed ID: 2984420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selectivity of the action of 1,3-dipropyl-8-phenylxanthine on the purine receptors of the intestines].
    Gmiro VE; Komissarov IV; Serdiuk SE; Kharin NA
    Farmakol Toksikol; 1988; 51(4):60-2. PubMed ID: 3191974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential sensitization of cardiac actions of adenosine in rats after chronic theophylline treatment.
    Lee HT; Thompson CI; Linden J; Belloni FL
    Am J Physiol; 1993 May; 264(5 Pt 2):H1634-43. PubMed ID: 8498576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism.
    Spealman RD
    Psychopharmacology (Berl); 1988; 95(1):19-24. PubMed ID: 3133696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imidazodiazepinediones: a new class of adenosine receptor antagonists.
    Daly JW; Hide I; Bridson PK
    J Med Chem; 1990 Oct; 33(10):2818-21. PubMed ID: 2213834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apparent affinity of 1,3-dipropyl-8-cyclopentylxanthine for adenosine A1 and A2 receptors in isolated tissues from guinea-pigs.
    Collis MG; Stoggall SM; Martin FM
    Br J Pharmacol; 1989 Aug; 97(4):1274-8. PubMed ID: 2790383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5'-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine.
    Martin PL; Potts AA
    J Pharmacol Exp Ther; 1994 Sep; 270(3):893-9. PubMed ID: 7932201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of brain adenosine receptors evokes vasodilation in skin arterioles.
    Proctor KG; Stojanov I; Bealer SL
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H457-62. PubMed ID: 1877671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxofylline, an antiasthmatic drug lacking affinity for adenosine receptors.
    Cirillo R; Barone D; Franzone JS
    Arch Int Pharmacodyn Ther; 1988; 295():221-37. PubMed ID: 3245738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of adenosine receptors in human pulmonary arteries.
    McCormack DG; Clarke B; Barnes PJ
    Am J Physiol; 1989 Jan; 256(1 Pt 2):H41-6. PubMed ID: 2912196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of P1-purinoceptors on rat duodenum and urinary bladder.
    Nicholls J; Hourani SM; Kitchen I
    Br J Pharmacol; 1992 Mar; 105(3):639-42. PubMed ID: 1628151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes.
    Ukena D; Schudt C; Sybrecht GW
    Biochem Pharmacol; 1993 Feb; 45(4):847-51. PubMed ID: 7680859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that a novel 8-phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo.
    Fredholm BB; Jacobson KA; Jonzon B; Kirk KL; Li YO; Daly JW
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):396-400. PubMed ID: 2438501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory effects of xanthines and adenosine analogs in rhesus monkeys.
    Howell LL; Morse WH; Spealman RD
    J Pharmacol Exp Ther; 1990 Sep; 254(3):786-91. PubMed ID: 2395111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological analysis of the interaction between purinoceptor agonists and antagonists in the guinea-pig taenia caecum.
    Prentice DJ; Shankley NP; Black JW
    Br J Pharmacol; 1995 Jun; 115(4):549-56. PubMed ID: 7582471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A2 and P2 purine receptor interactions and surfactant secretion in primary cultures of type II cells.
    Griese M; Gobran LI; Rooney SA
    Am J Physiol; 1991 Aug; 261(2 Pt 1):L140-7. PubMed ID: 1651664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.